Regal Investment Advisors LLC Invitae Corp Transaction History

Regal Investment Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$6.28 - $15.59 $135,434 - $336,213	-21,566 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$14.7 - $28.67 $124,876 - $243,551	8,495 Added 64.99%	21,566 $329,000
Q3 2021 Nov 05, 2021	BUY	$24.31 - $33.6 $15,218 - $21,033	626 Added 5.03%	13,071 $372,000
Q2 2021 Aug 09, 2021	BUY	$26.09 - $40.4 $324,690 - $502,778	12,445 New	12,445 $420,000
Q1 2021 May 12, 2021	SELL	$33.06 - $56.93 $296,349 - $510,320	-8,964 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$39.09 - $57.4 $350,402 - $514,533	8,964 New	8,964 $375,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Regal Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Regal Investment Advisors LLC with notifications on news.